GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (TSX:AKU) » Definitions » Loans Receivable

Akumin (TSX:AKU) Loans Receivable : C$0.0 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Akumin Loans Receivable?

Akumin's Loans Receivable for the quarter that ended in Sep. 2023 was C$0.0 Mil.


Akumin Loans Receivable Historical Data

The historical data trend for Akumin's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Loans Receivable Chart

Akumin Annual Data
Trend Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
Loans Receivable
Get a 7-Day Free Trial - - - - -

Akumin Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Akumin Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Akumin Loans Receivable Related Terms

Thank you for viewing the detailed overview of Akumin's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Akumin (TSX:AKU) Business Description

Traded in Other Exchanges
Address
8300 West Sunrise Boulevard, Plantation, FL, USA, 33322
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Executives
Marcus Quesenberry Senior Officer
Amy Michelle Adams Senior Officer

Akumin (TSX:AKU) Headlines

No Headlines